Frederick Barr
Concepts (176)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypertension, Pulmonary | 8 | 2010 | 128 | 1.280 |
Why?
| Citrulline | 6 | 2018 | 99 | 1.210 |
Why?
| Heart Defects, Congenital | 5 | 2011 | 609 | 0.770 |
Why?
| Anemia, Sickle Cell | 2 | 2018 | 94 | 0.730 |
Why?
| Nitric Oxide | 6 | 2015 | 298 | 0.710 |
Why?
| Cardiac Surgical Procedures | 4 | 2013 | 319 | 0.670 |
Why?
| Pain | 2 | 2018 | 400 | 0.540 |
Why?
| Cardiopulmonary Bypass | 2 | 2005 | 97 | 0.470 |
Why?
| Postoperative Complications | 4 | 2011 | 1036 | 0.460 |
Why?
| Intensive Care Units, Pediatric | 8 | 2015 | 185 | 0.390 |
Why?
| Infant | 14 | 2022 | 3797 | 0.390 |
Why?
| Shock, Septic | 1 | 2011 | 79 | 0.380 |
Why?
| Endothelium-Dependent Relaxing Factors | 1 | 2010 | 4 | 0.380 |
Why?
| Heart Ventricles | 2 | 2011 | 271 | 0.380 |
Why?
| Urea | 3 | 2009 | 83 | 0.370 |
Why?
| Carbamoyl-Phosphate Synthase (Ammonia) | 2 | 2006 | 3 | 0.360 |
Why?
| Heart Bypass, Right | 1 | 2009 | 7 | 0.350 |
Why?
| Genetic Variation | 2 | 2006 | 259 | 0.320 |
Why?
| Child, Preschool | 12 | 2021 | 4132 | 0.310 |
Why?
| Extracorporeal Circulation | 1 | 2007 | 12 | 0.310 |
Why?
| Coinfection | 2 | 2022 | 34 | 0.270 |
Why?
| Calpain | 1 | 2005 | 28 | 0.260 |
Why?
| Endothelin-1 | 1 | 2005 | 30 | 0.260 |
Why?
| Sepsis | 1 | 2007 | 253 | 0.240 |
Why?
| Reperfusion Injury | 1 | 2005 | 119 | 0.240 |
Why?
| Staphylococcus aureus | 1 | 2007 | 361 | 0.230 |
Why?
| Respiratory Syncytial Virus Infections | 1 | 2022 | 37 | 0.220 |
Why?
| Child | 12 | 2022 | 7312 | 0.220 |
Why?
| Infant, Newborn | 9 | 2015 | 2901 | 0.210 |
Why?
| Male | 15 | 2021 | 27350 | 0.200 |
Why?
| Critical Illness | 3 | 2011 | 344 | 0.200 |
Why?
| Female | 16 | 2021 | 28437 | 0.200 |
Why?
| Humans | 27 | 2022 | 54132 | 0.200 |
Why?
| Delirium | 2 | 2011 | 52 | 0.180 |
Why?
| Injections, Intravenous | 2 | 2010 | 148 | 0.170 |
Why?
| Palliative Care | 2 | 2011 | 188 | 0.160 |
Why?
| Acute Chest Syndrome | 1 | 2018 | 8 | 0.160 |
Why?
| Polymorphism, Genetic | 2 | 2010 | 195 | 0.160 |
Why?
| Adolescent | 6 | 2021 | 6890 | 0.150 |
Why?
| Arginine | 3 | 2010 | 183 | 0.150 |
Why?
| Prone Position | 2 | 2006 | 38 | 0.140 |
Why?
| Glutathione | 2 | 2010 | 330 | 0.140 |
Why?
| Gene Expression | 2 | 2011 | 667 | 0.140 |
Why?
| Respiratory Distress Syndrome, Newborn | 2 | 2006 | 53 | 0.130 |
Why?
| Direct Service Costs | 1 | 2015 | 6 | 0.130 |
Why?
| Prognosis | 2 | 2011 | 2116 | 0.130 |
Why?
| Prospective Studies | 5 | 2013 | 2607 | 0.120 |
Why?
| Clinical Protocols | 1 | 2015 | 122 | 0.120 |
Why?
| Administration, Inhalation | 2 | 2015 | 119 | 0.120 |
Why?
| Bronchodilator Agents | 1 | 2015 | 74 | 0.120 |
Why?
| Medical Records | 1 | 2013 | 92 | 0.110 |
Why?
| Education, Nursing | 1 | 2013 | 28 | 0.110 |
Why?
| Education, Medical | 1 | 2013 | 106 | 0.110 |
Why?
| Protein Array Analysis | 1 | 2011 | 28 | 0.110 |
Why?
| Patient Care Team | 1 | 2013 | 275 | 0.100 |
Why?
| Administration, Oral | 2 | 2010 | 459 | 0.100 |
Why?
| Severity of Illness Index | 2 | 2011 | 1084 | 0.100 |
Why?
| Critical Care | 2 | 2011 | 234 | 0.100 |
Why?
| Glutamate-Cysteine Ligase | 1 | 2010 | 22 | 0.090 |
Why?
| Respiration, Artificial | 3 | 2015 | 285 | 0.090 |
Why?
| Catalytic Domain | 1 | 2010 | 63 | 0.090 |
Why?
| Pediatrics | 1 | 2013 | 324 | 0.090 |
Why?
| Treatment Outcome | 4 | 2021 | 5596 | 0.090 |
Why?
| Heart Function Tests | 1 | 2009 | 14 | 0.090 |
Why?
| Respiratory Function Tests | 1 | 2009 | 98 | 0.080 |
Why?
| Thrombosis | 1 | 2011 | 243 | 0.080 |
Why?
| Metabolic Networks and Pathways | 1 | 2009 | 105 | 0.080 |
Why?
| Animals, Newborn | 2 | 2009 | 397 | 0.080 |
Why?
| Hospitalization | 2 | 2022 | 704 | 0.080 |
Why?
| Hypoplastic Left Heart Syndrome | 1 | 2009 | 97 | 0.080 |
Why?
| Databases as Topic | 1 | 2007 | 46 | 0.080 |
Why?
| Methicillin Resistance | 1 | 2007 | 25 | 0.080 |
Why?
| Risk Factors | 2 | 2018 | 3936 | 0.080 |
Why?
| Transcription, Genetic | 1 | 2009 | 419 | 0.080 |
Why?
| Community-Acquired Infections | 1 | 2007 | 42 | 0.080 |
Why?
| Clinical Trials as Topic | 1 | 2010 | 489 | 0.080 |
Why?
| Infusions, Intravenous | 1 | 2007 | 232 | 0.070 |
Why?
| Reproducibility of Results | 2 | 2011 | 1307 | 0.070 |
Why?
| DNA Primers | 1 | 2006 | 225 | 0.070 |
Why?
| Adult | 4 | 2018 | 14196 | 0.070 |
Why?
| Cohort Studies | 2 | 2011 | 1549 | 0.070 |
Why?
| Survival Rate | 1 | 2009 | 955 | 0.070 |
Why?
| Brain Diseases, Metabolic, Inborn | 1 | 2005 | 2 | 0.070 |
Why?
| Hyperammonemia | 1 | 2005 | 18 | 0.070 |
Why?
| Down Syndrome | 1 | 2006 | 100 | 0.070 |
Why?
| Polymerase Chain Reaction | 1 | 2006 | 533 | 0.070 |
Why?
| Hospitals, Pediatric | 3 | 2013 | 272 | 0.060 |
Why?
| Clinical Pharmacy Information Systems | 1 | 2004 | 3 | 0.060 |
Why?
| Drug Therapy, Computer-Assisted | 1 | 2004 | 2 | 0.060 |
Why?
| Medication Systems, Hospital | 1 | 2004 | 6 | 0.060 |
Why?
| Medication Errors | 1 | 2004 | 26 | 0.060 |
Why?
| Decision Support Systems, Clinical | 1 | 2004 | 26 | 0.060 |
Why?
| Whooping Cough | 1 | 2003 | 15 | 0.060 |
Why?
| Swine | 1 | 2005 | 430 | 0.060 |
Why?
| Research Design | 1 | 2006 | 374 | 0.060 |
Why?
| Dose-Response Relationship, Drug | 1 | 2007 | 1478 | 0.060 |
Why?
| Ornithine | 1 | 2003 | 14 | 0.060 |
Why?
| DNA | 1 | 2006 | 582 | 0.060 |
Why?
| Blood Urea Nitrogen | 1 | 2003 | 51 | 0.060 |
Why?
| Length of Stay | 2 | 2018 | 683 | 0.060 |
Why?
| United States | 2 | 2022 | 5172 | 0.050 |
Why?
| Hospitals | 1 | 2021 | 179 | 0.050 |
Why?
| Extracorporeal Membrane Oxygenation | 1 | 2003 | 308 | 0.050 |
Why?
| Vaccination | 1 | 2021 | 293 | 0.040 |
Why?
| Cough | 1 | 2018 | 54 | 0.040 |
Why?
| Dyspnea | 1 | 2018 | 78 | 0.040 |
Why?
| Cross-Sectional Studies | 1 | 2022 | 1678 | 0.040 |
Why?
| Fever | 1 | 2018 | 129 | 0.040 |
Why?
| Retrospective Studies | 3 | 2018 | 6387 | 0.040 |
Why?
| Supine Position | 2 | 2006 | 33 | 0.030 |
Why?
| Recurrence | 1 | 2018 | 692 | 0.030 |
Why?
| Genotype | 2 | 2010 | 607 | 0.030 |
Why?
| Carbamoyl-Phosphate Synthase I Deficiency Disease | 2 | 2005 | 2 | 0.030 |
Why?
| Age Factors | 1 | 2018 | 1198 | 0.030 |
Why?
| Forms and Records Control | 1 | 2013 | 12 | 0.030 |
Why?
| Obesity | 1 | 2022 | 1218 | 0.030 |
Why?
| Animals | 2 | 2009 | 14435 | 0.030 |
Why?
| Hospital Mortality | 1 | 2015 | 464 | 0.030 |
Why?
| Tennessee | 1 | 2011 | 43 | 0.030 |
Why?
| Medical Audit | 1 | 2011 | 23 | 0.030 |
Why?
| Comprehension | 1 | 2013 | 116 | 0.030 |
Why?
| Perioperative Care | 1 | 2011 | 42 | 0.030 |
Why?
| Neuropsychiatry | 1 | 2011 | 2 | 0.030 |
Why?
| Confusion | 1 | 2011 | 20 | 0.020 |
Why?
| Reference Standards | 1 | 2011 | 63 | 0.020 |
Why?
| Central Nervous System | 1 | 2011 | 85 | 0.020 |
Why?
| Observer Variation | 1 | 2011 | 139 | 0.020 |
Why?
| Psychometrics | 1 | 2011 | 241 | 0.020 |
Why?
| Exhalation | 1 | 2009 | 19 | 0.020 |
Why?
| Nitric Oxide Synthase Type I | 1 | 2009 | 22 | 0.020 |
Why?
| Attitude of Health Personnel | 1 | 2013 | 397 | 0.020 |
Why?
| Sus scrofa | 1 | 2009 | 39 | 0.020 |
Why?
| Perfusion | 1 | 2009 | 40 | 0.020 |
Why?
| Nitrates | 1 | 2009 | 49 | 0.020 |
Why?
| Transfection | 1 | 2010 | 410 | 0.020 |
Why?
| Ultrasonography | 1 | 2011 | 479 | 0.020 |
Why?
| Pressure | 1 | 2009 | 121 | 0.020 |
Why?
| Nitric Oxide Synthase Type III | 1 | 2009 | 84 | 0.020 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 540 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2011 | 1053 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2011 | 925 | 0.020 |
Why?
| Pulmonary Artery | 1 | 2009 | 152 | 0.020 |
Why?
| Hemodynamics | 1 | 2009 | 291 | 0.020 |
Why?
| Blotting, Western | 1 | 2009 | 685 | 0.020 |
Why?
| Practice Guidelines as Topic | 1 | 2011 | 491 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 682 | 0.020 |
Why?
| Amino Acids | 1 | 2009 | 367 | 0.020 |
Why?
| Chronic Disease | 1 | 2009 | 611 | 0.020 |
Why?
| Time Factors | 1 | 2013 | 3223 | 0.020 |
Why?
| Cells, Cultured | 1 | 2010 | 1755 | 0.020 |
Why?
| Precipitating Factors | 1 | 2005 | 2 | 0.020 |
Why?
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2005 | 4 | 0.020 |
Why?
| Fontan Procedure | 1 | 2006 | 56 | 0.020 |
Why?
| Risk Assessment | 1 | 2011 | 1363 | 0.020 |
Why?
| Lung | 1 | 2009 | 512 | 0.020 |
Why?
| Age of Onset | 1 | 2005 | 116 | 0.020 |
Why?
| Emergencies | 1 | 2005 | 92 | 0.020 |
Why?
| RNA, Messenger | 1 | 2009 | 1222 | 0.020 |
Why?
| Multivariate Analysis | 1 | 2006 | 646 | 0.020 |
Why?
| Double-Blind Method | 1 | 2006 | 747 | 0.020 |
Why?
| Apoptosis | 1 | 2010 | 1306 | 0.010 |
Why?
| Medical Records Systems, Computerized | 1 | 2004 | 36 | 0.010 |
Why?
| Hospitals, University | 1 | 2004 | 89 | 0.010 |
Why?
| Gene Expression Regulation | 1 | 2009 | 1075 | 0.010 |
Why?
| Gene Expression Profiling | 1 | 2009 | 1138 | 0.010 |
Why?
| Bone Marrow Transplantation | 1 | 2004 | 149 | 0.010 |
Why?
| Pilot Projects | 1 | 2006 | 805 | 0.010 |
Why?
| Chi-Square Distribution | 1 | 2004 | 318 | 0.010 |
Why?
| Blood Pressure | 1 | 2006 | 586 | 0.010 |
Why?
| Polymorphism, Single-Stranded Conformational | 1 | 2003 | 18 | 0.010 |
Why?
| Fatal Outcome | 1 | 2003 | 225 | 0.010 |
Why?
| Free Radical Scavengers | 1 | 2003 | 35 | 0.010 |
Why?
| Respiratory Insufficiency | 1 | 2003 | 129 | 0.010 |
Why?
| Models, Biological | 1 | 2004 | 824 | 0.010 |
Why?
| Mutation | 1 | 2004 | 1499 | 0.010 |
Why?
| Middle Aged | 1 | 2005 | 13094 | 0.010 |
Why?
|
|
Barr's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|